编辑 - 专题号 过敏性心肌病症
Celestino Sardu1,2,3,4
1Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80126 Naples, Italy.
Biomedicines
|February 27, 2026
概括
增高性心肌病变 (HCM) 是一种复杂的心脏疾病. 本研究探讨了其多样性和对患者护理的影响.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 病理生理学 病理生理学
背景情况:
- 增高性心肌病 (HCM) 是一种复杂而异质的心血管疾病.
- 了解HCM的各种临床表现和潜在机制对于有效的管理至关重要.
- 目前的知识缺口存在于完全描述HCM表型的谱和它们的进展.
研究的目的:
- 为了划分高伤心肌病 (HCM) 的异质性.
- 探索HCM的各种临床表现和遗传基础.
- 提高对HCM病理生理学的理解,以改善诊断和治疗策略.
主要方法:
- 系统性审查现有关于多变性心肌病 (HCM) 的文献.
- 分析临床数据,包括心声学,心脏MRI和遗传检测.
- 对患者队伍进行纵向跟踪,以评估疾病进展和结果.
主要成果:
- 基于形态学和功能,在多变性心肌病 (HCM) 中识别不同的表型集群.
- 特定遗传变异与特定的HCM表型和临床轨迹的相关性.
- 在不同HCM亚型中证明可变的疾病进展和风险分层.
结论:
- 超性心肌病 (HCM) 的特点是显著的异质性,影响临床结果.
- 个性化的诊断和治疗方法对于管理HCM至关重要.
- 对基因型-表型相关性的进一步研究将完善HCM的治疗点.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
568
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568
Cardiomyopathy V: Interprofessional Care
542
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
542
Cardiomyopathy I: Introduction and Classification
700
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
Cardiomyopathy II: Dilated Cardiomyopathy
667
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Cardiomyopathy IV: Restrictive Cardiomyopathy
655
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
655
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K


